Research Article

Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients

Table 3

Clinicopathological features related to the integrated classification subtypes.

Variable (%)EBV+ ()MSI ()E-cadherin aberrant ()p53 aberrant ()p53 normal () value

Gender0.168
 -Male59 (60.8%)6 (100)7 (53.8)16 (57.1)19 (61.3)11 (57.9)
 -Female38 (39.2%)0 (0)6 (46.2)12 (42.9)12 (38.7)8 (42.1)
Mean age at diagnosis (range)59 (28-85)61 (46-77)59 (36-85)56 (28-76)60 (39-80)65 (39-82)0.218
Age at diagnosis0.581
 -≥50 years80 (82.5)5 (83.3)9 (69.2)22 (78.6)27 (87.1)17 (89.5)
 -<50 years17 (17.5)1 (16.7)4 (30.8)6 (21.4)4 (12.9)2 (10.5)
History of gastrectomy0.055
 -Yes7 (7.2)1 (16.7)0 (0)3 (10.7)0 (0)3 (15.8)
 -No90 (92.8)5 (83.3)13 (100)25 (89.3)31 (100)16 (84.2)
History of gastric ulcer0.023
 -Yes3 (3.1)2 (33.3)0 (0)0 (0)0 (0)1 (5.3)
 -No94 (96.9)4 (66.7)13 (100)28 (0)31 (100)18 (94.7)
Tobacco smoking0.252
 -Yes25 (25.8)3 (50)1 (7.7)6 (21.4)10 (32.3)5 (26.3)
 -No72 (74.2)3 (50)12 (92.3)22 (78.6)21 (67.7)14 (73.7)
Tumor location0.186
 -Cardia31 (31.9)2 (33.3)4 (30.8)11 (39.3)12 (38.7)2 (10.5)
 -Noncardia66 (68.1)4 (66.7)9 (69.2)17 (60.7)19 (61.3)17 (89.5)
Tumor cells differentiation0.051
 -Well/moderate62 (63.9)2 (33.3)7 (53.8)15 (53.6)26 (83.9)12 (63.2)
 -Poor35 (36.1)4 (66.7)6 (46.2)13 (46.4)5 (16.1)7 (36.8)
Lauren classification0.002
 -Intestinal65 (67.1)3 (50)11 (84.6)11 (39.3)26 (83.9)14 (73.7)
 -Diffuse/mixed32 (32.9)3 (50)2 (15.4)17 (60.7)5 (16.1)5 (26.3)
HER2 immunostaining0.789
 -Positive9 (9.3)1 (16.7)1 (7.7)2 (7.1)2 (6.5)3 (15.8)
 -Negative88 (90.7)5 (83.3)12 (92.3)26 (92.9)29 (93.5)16 (84.2)
PD-L1 immunostaining0.324
 -Positive6 (15.8)1 (33.3)3 (50)0 (0)1 (9.1)1 (12.5)
 -Negative32 (84.2)2 (66.7)3 (50)10 (100)10 (90.9)7 (87.5)

EBV: Epstein-Barr virus; MSI: microsatellite instability; previously reported [13].